Peter Fraser
Co-founder and chairman

Peter is a world-leading expert in gene expression and chromosomal architecture and inventor of the PCHi-C technology. During the scientific discovery and early concept of the business, Peter led the Nuclear Dynamics Programme at the Babraham Institute in Cambridge, UK. Peter is currently a Chair at Florida State University where he is Director of the Centre for Genomics and Personalised Medicine. 

Stefan Schoenfelder
Co-founder and board member

Stefan is a recognised expert in the area of 3D genome organisation and function. Having led the development of Capture Hi-C while working in Prof. Fraser’s laboratory, Stefan is now a group leader in the Epigenetics Programme at the Babraham Institute. Stefan is closely involved in the technology development and supports establishing the company’s research programmes.

Mikhail Spivakov
Co-founder and board member

Mikhail is a recognised expert in regulatory genomics and computational biology. Mikhail’s group at the Babraham Institute worked closely with the Fraser lab to develop the computational approaches for analysis of 3D genomic data. Mikhail is currently a group leader at the MRC London Institute of Medical Sciences and a Honorary Senior Lecturer at Imperial College London.

Debora Lucarelli
CEO

Debora brings a wealth of experience in technology development, together with a track record of successfully delivering large-scale projects in academia and industry.  Her key contributions, on projects spanning genetic and protein platforms, have included operational support, technical leadership and strategic insight. At Enhanc3d Genomics, Debora is driving the development of the PCHi-C platforms, establishing partnerships across the pharma and biotech industry, and actively advocating the advent of a 3D genomics era.

Lyubomira Chakalova
Senior Scientist

Lyubomira worked in the Fraser group at Babraham for 10 years and has over 20 years of experience in cutting-edge methodology development in molecular and cellular biology. Having led her own independent research group previously, Lyubomira has put her academic career on hold to fully focus on the company’s technology.

Michiel Thiecke
Senior Computational Biologist

Michiel completed his PhD in Mikhail Spivakov’s lab studying the role of architectural chromatin proteins in gene control. Michiel leads the development of Enhanc3d Genomics bioinformatic pipeline and the analysis and interpretation our in-house data.

Tol Trimborn
Business Development Partner

Tol is a serial biotech entrepreneur with a research background in gene regulation and has many years of experience in starting innovative biotechs including DNage, Arcarios and GadetaTol supports the company advising on market directions and company business strategies.